Illumina acquires GRAIL | West Fountain Portfolio Company GRAIL Acquired for over USD 8B (Cash & Stock) via M&A
2021.10.08
The Fourth Partner Meeting of West Fountain Global Fund Successfully Concluded
2021.09.03
万容红土中美基金第四次合伙人大会圆满召开
2021.09.03
被投企业动态｜科州药业与罗氏制药签署合作协议——携手创新，聚焦中国肿瘤患者需求
2021.08.10
Portfolio Update: Impact Therapeutics's Wee1 Inhibitor MP7068 approved for Phase 1 Clinical TrialKechow Pharma and Roche Pharmaceuticals Signed a Cooperation Agreement – to collaborate, Innovate and Focus on the Needs of Chinese Cancer Patients
2021.08.10
Portfolio Update: West Fountain portfolio company Fudan Microelectronics (FMSH) listed in the SSE STAR Market
2021.08.05
被投企业动态 | 万容红土中美基金投资的复旦微电登陆科创板
2021.08.05
ASR Microelectronics (“ASR”) passed in the SSE STAR Market Listing Review Committee Meeting | West Fountain portfolio company ASR will be listed soon as a publicly traded company
Portfolio Update｜GRAIL demonstrated the significant progress of the PATHFINDER project by launching the pioneering multi-cancer early detection blood test: Galleri
2021.06.04
Portfolio Update:TytoCare is Ranked 22 as One of the 50 Most Promising Israeli Startups
